Skip to main content
SpringerLink
Log in

Nutrition in Children with Liver Disease: Evaluation and Management

  • Chapter
  • First Online:
Diseases of the Liver in Children

Abstract

The liver is the major organ for maintaining normal homeostasis of both macronutrients (proteins, carbohydrates, and fat including essential fatty acids) and micronutrients (vitamins and minerals). Therefore, children with significant liver disease, especially those with chronic cholestasis, cirrhosis, or end-stage liver disease, often demonstrate impaired nutrient metabolism as well as possible malabsorption or maldigestion of nutrients. Routine assessments of nutritional status, appropriate supplementations, and nutritional intervention or rehabilitation (if needed) are crucial in managing these children. The roles of various diets in children who suffer from end-stage liver disease and complications from hepatic dysfunction such as hepatic encephalopathy or ascites have been widely studied. During the past two decades, many children with chronic end-stage or life-threatening liver disease have undergone liver transplantation as a therapeutic option. Nutritional support also plays an essential role in managing these children both before and after the transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.

    Article  PubMed  CAS  Google Scholar 

  2. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351–62.

    Article  PubMed  CAS  Google Scholar 

  3. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 1991;254:421–3.

    Article  PubMed  CAS  Google Scholar 

  4. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 1997;185:171–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Muller MJ, Pirlich M, Balks HJ, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem. 1994;32:749–58.

    PubMed  CAS  Google Scholar 

  6. Petrides AS, DeFronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol. 1989;8:107–14.

    Article  PubMed  CAS  Google Scholar 

  7. Muller MJ, Willman O, Rieger A, et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology. 1992;102:2033–41.

    PubMed  CAS  Google Scholar 

  8. Selberg O, Burchert W, van der Hoff J, et al. Insulin resistance in cirrhosis. Positron emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest. 1993;91:1897–902.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Petrides AS, Luzi L, Reuben A, Riely C, De Fronzo RA. Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis. Hepatology. 1991;14:432–41.

    Article  PubMed  CAS  Google Scholar 

  10. Freeman Jr RB, Wisener RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851–8.

    Article  PubMed  Google Scholar 

  11. Owen OE, Trapp VE, Reichard JA, et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest. 1983;72:1821–32.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Merli M, Erickson SL, Hagenfeldt H, Wahren J. Splanchnic and peripheral exchange of FFA in patients with liver cirrhosis. J Hepatol. 1986;3:348–55.

    Article  PubMed  CAS  Google Scholar 

  13. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, et al. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130:e607–14.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ryckman F, Fisher R, Pedersen S, Dittrich V, et al. Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg. 1993;28:382–5.

    Article  PubMed  CAS  Google Scholar 

  15. Florez DA, Aranda-Michel J. Nutritional management of acute and chronic liver disease. Semin Gastrointest Dis. 2002;13:169–78.

    PubMed  Google Scholar 

  16. Dowling RH. Compensatory changes in intestinal absorption. Br Med Bull. 1967;23:275–8.

    PubMed  CAS  Google Scholar 

  17. Bahr MJ, Manns MP. Function of the immune system in liver cirrhosis. Gastroenterology. 1993;39:601–7.

    Google Scholar 

  18. Badley BWD, Murphy GM, Bouchier IAD, et al. Diminished micellar phase lipid in patients with chronic nonalcoholic liver disease and steatorrhea. Gastroenterology. 1970;58:781–9.

    PubMed  CAS  Google Scholar 

  19. Sanders T. Essential fatty acids. In: Macrae R, Robinson RK, Sadler MJ, editors. Encyclopaedia of food science, food technology, and nutrition. London: Academic; 1993. p. 1651–4.

    Google Scholar 

  20. Hansen AE, Haggard ME, Boelsche AN, et al. Essential fatty acids in infant nutrition III. Clinical manifestations of linoleic acid deficiency. J Nutr. 1958;60:565–76.

    Google Scholar 

  21. Holman RT, Johnson SB, Hatch F. A case of human linolenic acid deficiency involving neurological abnormalities. Am J Clin Nutr. 1982;35:617–23.

    PubMed  CAS  Google Scholar 

  22. Wene JD, Connor WE, Den Besten L. The development of EFA deficiency in healthy men fed fat free diets intravenously and orally. J Clin Invest. 1975;56:127–34.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Clandinin MT, Chappell JE, Heim T, et al. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev. 1981;5:355–66.

    Article  PubMed  CAS  Google Scholar 

  24. Pettei MJ, Daftary S, Levine JJ. EFA deficiency associated with the use of a MCT infant formula in pediatric hepatobiliary disease. Am J Clin Nutr. 1991;53:1217–21.

    PubMed  CAS  Google Scholar 

  25. Neuringer M, Connor WE, Lin DS, Barstad L, Luck SJ. Biochemical and functional effects of prenatal and postnatal omega-3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci U S A. 1986;83:185–294.

    Google Scholar 

  26. Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development in very low birth weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci. 1992;33:2365–76.

    PubMed  CAS  Google Scholar 

  27. Carlson SE, Werkman SH, Tolley EA. Effect of long-chain N-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 1996;63(5):687–97.

    PubMed  CAS  Google Scholar 

  28. Chase HP, Long MA, Lavin MH. Cystic fibrosis and malnutrition. J Pediatr. 1979;95:337–47.

    Article  PubMed  CAS  Google Scholar 

  29. Bender DA, Bender AE. Nutrition, a reference handbook. Oxford: Oxford University Press; 1997. p. 131–3.

    Google Scholar 

  30. Duerksen DR, Nehra V, Palombo JD, Ahmad A, Bristrian BR. Essential fatty acid deficiencies in patients with chronic liver disease are not reversed by short-term intravenous lipid supplementation. Dig Dis Sci. 1999;44:1342–8.

    Article  PubMed  CAS  Google Scholar 

  31. Burke PA, Ling PR, Forse RA, Bristrian BR. Conditionally essential fatty acid deficiencies in end-stage liver disease. Nutrition. 1999;15:302–4.

    Article  PubMed  CAS  Google Scholar 

  32. Kaufman SS, Scrivner DJ, Murray ND, et al. Influence of portagen and pregestimil on essential fatty acid status in infantile liver disease. Pediatrics. 1992;89:151–4.

    PubMed  CAS  Google Scholar 

  33. Feranchak AP, Gralla J, King R, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology. 2005;42:782–92.

    Article  PubMed  CAS  Google Scholar 

  34. Phillips JR, Angulo P, Petterson T, et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol. 2001;96:2745–50.

    Article  PubMed  CAS  Google Scholar 

  35. Sherwin JC, Reacher MH, Dean WH, et al. Epidemiology of vitamin A deficiency and xerophthalmia in at-risk populations. Trans R Soc Trop Med Hyg. 2012;106:205–14.

    Article  PubMed  CAS  Google Scholar 

  36. Lippe B, Hensen L, Mendoza G, et al. Chronic vitamin A intoxication. Am J Dis Child. 1981;135:634–6.

    Article  PubMed  CAS  Google Scholar 

  37. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.

    Google Scholar 

  38. Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83:191–201.

    PubMed  CAS  Google Scholar 

  39. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2011.

    Google Scholar 

  40. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.

    Article  PubMed  CAS  Google Scholar 

  41. Heubi JE, Hollis BW, Specker B, et al. Bone disease in chronic childhood cholestasis. Vitamin D adsorption and metabolism. Hepatology. 1989;9:258–64.

    Article  PubMed  CAS  Google Scholar 

  42. Bucuvalas JC, Heubi JE, Specker BL, et al. Calcium absorption in bone disease associated with liver cholestasis during childhood. Hepatology. 1990;12:1200–5.

    Article  PubMed  CAS  Google Scholar 

  43. Heubi JE, Higgins JV, Argao EA, et al. The role of magnesium in the pathogenesis of bone disease in childhood cholestatic liver disease: a preliminary report. J Pediatr Gastroenterol Nutr. 1997;25:301–6.

    Article  PubMed  CAS  Google Scholar 

  44. Argao EA, Balistreri WF, Hollis BW, et al. Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis. Hepatology. 1994;20:598–603.

    Article  PubMed  CAS  Google Scholar 

  45. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press; 2010.

    Google Scholar 

  46. Sokol RJ, Heubi JE, Iannaccone S, et al. Mechanisms causing vitamin E deficiency during chronic childhood cholestasis. Gastroenterology. 1983;85:1172–82.

    PubMed  CAS  Google Scholar 

  47. Sokol RJ, Heubi JE, Iannaccone ST, et al. Vitamin E deficiency with normal serum vitamin E concentration in children with chronic cholestasis. N Engl J Med. 1984;310:1209–12.

    Article  PubMed  CAS  Google Scholar 

  48. Gordon HH, Nitowsky HM, Cornblath M. Studies of tocopherol deficiency in infants and children. 1. Hemolysis of erythrocytes in hydrogen peroxide. Am J Dis Child. 1955;90:669–81.

    CAS  Google Scholar 

  49. Cynamon HA, Isenberg JN, Nguyen CH. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. Clin Chim Acta. 1985;151:169–76.

    Article  PubMed  CAS  Google Scholar 

  50. Refat M, Moore TJ, Kazui M, et al. Utility of breathe ethane as a noninvasive biomarker of vitamin E status in children. Pediatr Res. 1991;30:396–403.

    Article  PubMed  CAS  Google Scholar 

  51. Sokol RJ, Guggenheim MA, Iannaccone ST, et al. Improved neurologic function flowing correction of vitamin E deficiency in children with chronic cholestasis. N Engl J Med. 1985;313:1580–6.

    Article  PubMed  CAS  Google Scholar 

  52. Olson RE. The function and metabolism of vitamin K. Annu Rev Nutr. 1984;4:281–337.

    Article  PubMed  CAS  Google Scholar 

  53. Bancroft J, Cohen MB. Intracranial hemorrhage due to vitamin K deficiency in breast fed infants with cholestasis. J Pediatr Gastroenterol Nutr. 1993;16:78–80.

    Article  PubMed  CAS  Google Scholar 

  54. Yanofsky RA, Jackson VG, Lilly JR, et al. The multiple coagulopathies of biliary atresia. Am J Hematol. 1984;16:171–80.

    Article  PubMed  CAS  Google Scholar 

  55. Hambridge KM, Casey CE, Krebs NF. Zinc. In: Mertz W, editor. Trace elements in human and animal nutrition, vol. 2. 5th ed. Florida: Academic; 1986. p. 12–4.

    Google Scholar 

  56. Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ. Zinc and liver disease. Nutr Clin Pract. 2012;27:8–20.

    Article  PubMed  Google Scholar 

  57. Sazawal S, Black RE, Bhan MK, et al. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med. 1995;333:839–44.

    Article  PubMed  CAS  Google Scholar 

  58. Roy SK, Tomkins AM, Akramuzzaman SM, et al. Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea. Arch Dis Child. 1997;77:196–200.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  59. Ferenci P, Steindl-Munda P, Vogel W, et al. Diagnostic value of quantitative hepatic copper determination in patients with Wilson’s Disease. Clin Gastroenterol Hepatol. 2005;3:811–8.

    Article  PubMed  CAS  Google Scholar 

  60. Grunebaum M, Horodniceanu C, Steinherz R. The radiographic manifestations of bone changes in copper deficiency. Pediatr Radiol. 1980;9:101–4.

    Article  PubMed  CAS  Google Scholar 

  61. Jiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010;2100:869–81.

    Article  CAS  Google Scholar 

  62. Keshan Disease Research Group. Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J (Engl). 1979;92:477–82.

    Google Scholar 

  63. Rotruck JT, et al. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973;179:588–90.

    Article  PubMed  CAS  Google Scholar 

  64. Fleming CR, Lie JT, McCall JT, et al. Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterology. 1982;83:689–93.

    PubMed  CAS  Google Scholar 

  65. van Rij A, Thomson CD, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr. 1979;32:2076–85.

    PubMed  Google Scholar 

  66. Thuluvath PJ, Triger DR. Selenium in chronic liver disease. J Hepatol. 1992;14:176–82.

    Article  PubMed  CAS  Google Scholar 

  67. Chin SE, Shepherd RW, Thomas BJ, et al. The nature of malnutrition in children with end-stage liver disease awaiting orthotopic liver transplantation. Am J Clin Nutr. 1992;56:164–8.

    PubMed  CAS  Google Scholar 

  68. Levander OA. Considerations on the assessment of selenium status. Fed Proc. 1985;44:2579–83.

    PubMed  CAS  Google Scholar 

  69. Mertz W. Chromium occurrence and function in biological systems. Physiol Rev. 1969;49:163–239.

    PubMed  CAS  Google Scholar 

  70. Freund H, Atamiam S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA. 1979;241:496–8.

    Article  PubMed  CAS  Google Scholar 

  71. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30:531–8.

    PubMed  CAS  Google Scholar 

  72. Bavdekar A, Bhave S, Pandit A. Symposium on hospital-based nutrition: nutrition management in chronic liver disease. J Trauma Inj Infect Crit Care. 2004;56:37–44.

    Article  CAS  Google Scholar 

  73. Eriksson LS, Persson A, Wahren J. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy. Gut. 1982;23:801–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  74. Wahren J, Denis J, Desurmont P, et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983;3:475–80.

    Article  PubMed  CAS  Google Scholar 

  75. Horst D, Grace ND, Conn HO, et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984;4:279–87.

    Article  PubMed  CAS  Google Scholar 

  76. Cascino A, Cangioano C, Calcaterra V, et al. Plasma amino acids imbalance in patients with liver disease. Am J Dig Dis. 1978;23:591–8.

    Article  PubMed  CAS  Google Scholar 

  77. Rossi-Francelli F, Freund H, Krause R, et al. Induction of coma in normal dogs by the infusion of aromatic amino acids and its prevention by the addition of branched-chain amino acids. Gastroenterology. 1982;83:664–71.

    Google Scholar 

  78. Fisher JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet. 1971;ii:75–80.

    Article  Google Scholar 

  79. Rossi-Francelli F, Riggio O, Cangiano C, et al. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study. Dig Dis Sci. 1982;27:929–35.

    Article  Google Scholar 

  80. McGhee A, Henderson JM, Millikan Jr WJ, et al. Comparison of the effects of hepatic-aid and casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg. 1983;197:288–93.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  81. Fabbri A, Magrini N, Bianchi G, et al. Overview of randomized clinical trials of oral branched-chain fatty acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr. 1996;20:159–64.

    Article  PubMed  CAS  Google Scholar 

  82. Charlton CP, Buchanan E, Holden CE, et al. Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy. Arch Dis Child. 1992;67:603–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  83. Helton WS. Nutritional issues in hepatobiliary surgery. Semin Liver Dis. 1994;14:140–57.

    Article  PubMed  CAS  Google Scholar 

  84. Fan ST, Lo CM, Lai ECS, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547–52.

    Article  PubMed  CAS  Google Scholar 

  85. Garrison RN, Cryer HM, Howard DA, Polk HC. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  86. Bonkovsky HL, Fiellin DA, Smith GS, et al. A randomized controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. 1. Short-term effects on liver function. Am J Gastroenterol. 1991;86:1200–8.

    PubMed  CAS  Google Scholar 

  87. Kearns PJ, Young H, Garcia G, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 1992;102:200–5.

    PubMed  CAS  Google Scholar 

  88. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology. 1990;98:715–20.

    PubMed  CAS  Google Scholar 

  89. Moukarzel AA, Najm I, Vargas J, et al. Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc. 1900;22:1560–3.

    Google Scholar 

  90. Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation. 1994;57:469–72.

    Article  PubMed  CAS  Google Scholar 

  91. Prijatmoko D, Strauss BJG, Lambert JR, et al. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology. 1993;105:1839–45.

    PubMed  CAS  Google Scholar 

  92. Heymsfield SB, Artega C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37:478–94.

    PubMed  CAS  Google Scholar 

  93. Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a department of veterans affairs cooperative study. Hepatology. 1993;17:564–76.

    Article  PubMed  CAS  Google Scholar 

  94. Thomas S, Wolfe SE, Murphy KD, Chinkes DL, Herndon DN. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. J Trauma Inj Infect Crit Care. 2004;56:32–44.

    Google Scholar 

  95. Verboeket-van de Venne WPGH, Westerp KR, Van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut. 1995;36:110–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  96. Chin SE, Shepherd RW, Thomas BJ, et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr. 1992;56:158–63.

    PubMed  CAS  Google Scholar 

  97. deLedinghen V, Beau P, Mannant PR, et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci. 1997;42:536–41.

    Article  CAS  Google Scholar 

  98. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006;118:e197–201.

    Article  PubMed  Google Scholar 

  99. Le HD, deMeijer VE, Robinson EM, et al. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-0 dependent children. Am J Clin Nutr. 2011;94:749–58.

    Article  PubMed  CAS  Google Scholar 

  100. Diamond IR, Sterescu A, Pencharz PB, et al. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009;48:209–15.

    Article  PubMed  CAS  Google Scholar 

  101. Xu Z, Li Y, Wang J, et al. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Clin Nutr. 2012;31:217–23.

    Article  PubMed  CAS  Google Scholar 

  102. Michel H, Bories P, Aubin JP, et al. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acid mixture: a controlled study in 70 patients. Liver. 1985;5:282–9.

    PubMed  CAS  Google Scholar 

  103. Vilstrup H, Gluud C, Hardt F, et al. Branched-chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J Hepatol. 1990;10:291–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, 175 Cambridge Street, Boston, MA, 02114, USA

    Stephen C. Hardy MD, Pornthep Tanpowpong MD & Ronald E. Kleinman MD

Authors
  1. Stephen C. Hardy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pornthep Tanpowpong MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronald E. Kleinman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen C. Hardy MD .

Editor information

Editors and Affiliations

  1. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Karen F. Murray

  2. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Simon Horslen

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hardy, S.C., Tanpowpong, P., Kleinman, R.E. (2014). Nutrition in Children with Liver Disease: Evaluation and Management. In: Murray, K., Horslen, S. (eds) Diseases of the Liver in Children. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9005-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9005-0_27

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9004-3

  • Online ISBN: 978-1-4614-9005-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation